close
OpenCongress will be shutting down on March 1st. But don't worry: We're doing so for a number of good reasons. From then on, we'll be redirecting users to the excellent GovTrack, where you can continue to monitor Congress.

H.R.573 - To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

view all titles (1)

All Bill Titles

  • Official: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs. as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 2
  • All-Time: 2,549
 
Introduced
 
House
Passes
 
Senate
Passes
 
President
Signs
 

 
01/15/09
 
 
 
 
 
 
 

Official Summary

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new dr

Official Summary

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from commencing to manufacture, market, sell, or distribute a generic version of such drug from the time of the receipt of notice from the generic manufacturer that an abbreviated new drug application has been submitted for approval until the expiration or forfeiture of the exclusivity period granted to the generic manufacturer.

...Read the Rest




Vote on This Bill

0% Users Support Bill

0 in favor / 2 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC